M&A
The first quarter of 2026 has concluded with a historic roar, as global Mergers and Acquisitions (M&A) reached a staggering $438 billion in deal value. This surge, a 155% increase over the same period in 2025, signals a definitive return of "animal spirits" to corporate boardrooms.
Abbott Laboratories
CHICAGO — In a move that fundamentally reshapes the global diagnostics landscape, Abbott Laboratories (NYSE: ABT) officially completed its $21 billion acquisition of Exact Sciences (NASDAQ: EXAS) today, March 23, 2026. The closing of the deal marks the end of a high-stakes transition period and the beginning of a new era
Abbott Laboratories
Abbott Laboratories (NYSE: ABT) saw its stock price tumble by nearly 10% in early trading on January 22, 2026, following the release of its fourth-quarter 2025 financial results. Despite meeting bottom-line expectations for earnings per share, the healthcare giant reported a significant revenue miss that spooked investors, driven primarily by
Abbott Laboratories
Abbott Laboratories (NYSE: ABT) saw its shares retreat by 5.8% in early trading on Thursday, January 22, 2026, following the release of its fourth-quarter financial results. Despite delivering an adjusted earnings per share (EPS) of $1.50—narrowly edging out the $1.49 consensus estimate—the medical device giant’
Healthcare M&A
As 2026 begins, the healthcare sector is undergoing its most profound transformation in decades. Driven by a relentless push toward "precision medicine" and the industrialization of artificial intelligence, the industry has seen a staggering 150.5% year-over-year jump in deal value. The catalyst for this explosive growth was
Synlait Milk
New Zealand's Synlait Milk (NZX: SML) has announced a reduction in its annual base milk price forecast for the 2025/2026 season, signaling persistent challenges within the global dairy commodity market. The revised forecast, now set at NZ$9.50 per kilogram of milk solids (kgMS), down from